PMDA — authorised 27 March 2023
- Marketing authorisation holder: PDRadiopharma Inc
- Status: approved
🇯🇵 Phyliance in Japan
PMDA authorised Phyliance on 27 March 2023
Marketing authorisation
Phyliance in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Phyliance approved in Japan?
Yes. PMDA authorised it on 27 March 2023.
Who is the marketing authorisation holder for Phyliance in Japan?
PDRadiopharma Inc holds the Japanese marketing authorisation.